StocktoriaAprea Therapeutics, Inc. APRE
Nasdaq · XNAS · stock · Pharmaceutical Preparations
Chart by TradingView
0/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$13.2M | -$14.3M | -$15.5M | -$113.4M | -$37.4M |
| Net income | -$12.6M | -$13.0M | -$14.3M | -$112.7M | -$37.1M |
| Operating cash flow | -$12.9M | -$13.6M | -$12.2M | -$25.0M | -$37.7M |
| Free cash flow | — | -$13.6M | -$12.3M | — | — |
| Total assets | $15.9M | $24.0M | $22.7M | $30.2M | $56.8M |
| Total liabilities | — | — | — | $3.2M | $7.3M |
| Shareholders' equity | $12.4M | $19.3M | $17.0M | $25.6M | $49.5M |
| Ratios | |||||
| Return on assets | -79.1% | -54.0% | -63.1% | -373.6% | -65.3% |
| Return on equity | -101.3% | -67.1% | -84.3% | -439.3% | -75.0% |
| Current ratio | 5.63 | 7.01 | 5.14 | 9.42 | 7.73 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 25,100 | $19,149 |
Why these scores methodology →
Piotroski F-score: 0/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001781983 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.